Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors

Biologic response modifiers to decrease inflammation: Focus on infection risks

(2017) Nicole Le Saux   Paediatrics & Child Health

NASPGHAN Clinical Report

(2016) Monica I. Ardura et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Infecção sistêmica e localizada por Candida spp. em pacientes reumatológicos em terapia anti‐TNF

(2016) Nadia E. Aikawa et al.   Revista Brasileira De Reumatologia

Effectiveness and Safety of Immunomodulators With Anti–Tumor Necrosis Factor Therapy in Crohn’s Disease

(2015) Mark T. Osterman et al.   Clinical Gastroenterology and Hepatology

Histoplasmosis Complicating Tumor Necrosis Factor–α Blocker Therapy: A Retrospective Analysis of 98 Cases

(2015) Paschalis Vergidis et al.   CLINICAL INFECTIOUS DISEASES

Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis

(2015) Jasvinder A Singh et al.   LANCET

Successful Treatment of Primary Cutaneous Mucormycosis Complicating Anti-TNF Therapy with a Combination of Surgical Debridement and Oral Posaconazole

(2015) Jose F. Camargo et al.   MYCOPATHOLOGIA

Atypical Cutaneous Blastomycosis in a Child With Juvenile Idiopathic Arthritis on Infliximab

(2015) R. J. Smith et al.   PEDIATRICS

Biologic-Associated Infections in Pediatric Rheumatology

(2015) Gerd Horneff   Current Rheumatology Reports

Treatment of Pediatric Takayasu Arteritis With Infliximab and Cyclophosphamide

(2015) Sara Stern et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Risks of Serious Infection or Lymphoma With Anti–Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review

(2014) Parambir S. Dulai et al.   Clinical Gastroenterology and Hepatology

A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors

(2014) Heather M. Walters et al.   CLINICAL RHEUMATOLOGY

Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years

(2014) Daniel J. Kingsbury et al.   CLINICAL RHEUMATOLOGY

Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting

(2014) Maarit Tarkiainen et al.   RHEUMATOLOGY

Different tumor necrosis factor α antagonists have different effects on host susceptibility to disseminated and oropharyngeal candidiasis in mice

(2014) Hyunsook Park et al.   Virulence

Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry

(2014) Heinrike Schmeling et al.   Arthritis & Rheumatology

Histoplasmosis in Patients With Cell-Mediated Immunodeficiency: Human Immunodeficiency Virus Infection, Organ Transplantation, and Tumor Necrosis Factor-  Inhibition

(2014) K. Luckett et al.   Open Forum Infectious Diseases

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

(2013) John W Baddley et al.   ANNALS OF THE RHEUMATIC DISEASES

Brief Report: Incidence of Selected Opportunistic Infections Among Children With Juvenile Idiopathic Arthritis

(2013) Timothy Beukelman et al.   ARTHRITIS AND RHEUMATISM

Infections in Children and Adolescents With Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Treated With Tumor Necrosis Factor-  Inhibitors: Systematic Review of the Literature

(2013) S. S. Toussi et al.   CLINICAL INFECTIOUS DISEASES

Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature

(2013) Archana Jain et al.   Immunotherapy

Endemic Fungal Infections in Inflammatory Bowel Disease Associated with Anti-TNF Antibody Therapy

(2013) Miguel E. Ordonez et al.   INFLAMMATORY BOWEL DISEASES

Infliximab for Crohn’s Disease: The First 500 Patients Followed Up Through 2009

(2012) Jennifer L. Seminerio et al.   DIGESTIVE DISEASES AND SCIENCES

Risk of Infection and Prevention in Pediatric Patients With IBD

(2012) Gigi Veereman-Wauters et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Vertebral Osteomyelitis Due to Candida parapsilosis in a Child With Crohn Disease While Receiving Anti-TNF Therapy

(2012) Andrew Huang et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Safety and Efficacy of Etanercept in a Cohort of Patients with Juvenile Idiopathic Arthritis Under 4 Years of Age

(2012) C. BRACAGLIA et al.   JOURNAL OF RHEUMATOLOGY

Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy

(2012) Sotirios Tsiodras et al.   MAYO CLINIC PROCEEDINGS

A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease

(2011) R. K. Russell et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Steroid-Refractory Acute GVHD: Lack of Long-Term Improved Survival Using New Generation Anticytokine Treatment

(2011) Aliénor Xhaard et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis

(2011) Jeffrey Hyams et al.   Clinical Gastroenterology and Hepatology

Infectious Complications Associated with Immunomodulating Biologic Agents

(2011) Sophia Koo et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry

(2011) María José Pérez-Sola et al.   MEDICINA CLINICA

Acute pulmonary histoplasmosis in a patient with uveitis after infliximab therapy

(2011) Lik Thai Lim et al.   INTERNATIONAL OPHTHALMOLOGY

Scedosporium infection in a patient with anti-tnfα therapy

(2011) SibaP Raychaudhuri et al.   INDIAN JOURNAL OF DERMATOLOGY

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension

(2010) N. Ruperto et al.   ANNALS OF THE RHEUMATIC DISEASES

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

(2010) D. Salmon-Ceron et al.   ANNALS OF THE RHEUMATIC DISEASES

Bacteremias and invasive fungal diseases in children receiving etanercept for steroid-resistant acute GVHD

(2010) M Faraci et al.   BONE MARROW TRANSPLANTATION

Infectious Complications Associated with Immunomodulating Biologic Agents

(2010) Sophia Koo et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series

(2010) Jennifer L. Dotson et al.   INFLAMMATORY BOWEL DISEASES

A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease

(2010) W. Miehsler et al.   Journal of Crohns & Colitis

Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: An Australian and New Zealand experience

(2010) Ian C Lawrance et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Disseminated Histoplasmosis and Pneumocystis Pneumonia in a Child With Crohn Disease Receiving Infliximab

(2010) James Tschudy et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry

(2009) J D Greenberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Pneumocystis jirovecipneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case-control study of 21 patients

(2009) Yukiko Komano et al.   ARTHRITIS AND RHEUMATISM

Incidence and nature of infectious disease in patients treated with anti-TNF agents

(2009) Siba P. Raychaudhuri et al.   AUTOIMMUNITY REVIEWS

Recognition, Diagnosis, and Treatment of Histoplasmosis Complicating Tumor Necrosis Factor Blocker Therapy

(2009) Chadi A. Hage et al.   CLINICAL INFECTIOUS DISEASES

Infectious Complications Associated with Monoclonal Antibodies and Related Small Molecules

(2009) E. M. T. Salvana et al.   CLINICAL MICROBIOLOGY REVIEWS

Invasive Fungal Infections in the Era of Biologics

(2009) Tamra M. Arnold et al.   CLINICS IN CHEST MEDICINE

Endemic Fungal Infections in Patients Receiving Tumour Necrosis Factor-α Inhibitor Therapy

(2009) Jeannina A. Smith et al.   DRUGS

Improved Survival and Preserved Antiviral Responses After Combination Therapy With Daclizumab and Infliximab in Steroid-refractory Graft-Versus-Host Disease

(2009) Kanchan Rao et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Aspergillosis in patients treated with monoclonal antibodies

(2009) Wagner L. Nedel et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Pulmonary scedosporium infection as a complication of infliximab therapy for ankylosing spondylitis

(2009) J C Ngai et al.   THORAX

Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy

(2009) Ariane Leboime et al.   ARTHRITIS RESEARCH & THERAPY

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

Invasive Mucormycosis of the Maxillary Sinus: Extensive Destruction with an Indolent Presentation

(2008) Eric Odessey et al.   Surgical Infections

TNFα blockade in human diseases: An overview of efficacy and safety

(2007) Jan Lin et al.   CLINICAL IMMUNOLOGY